Baystate Wealth Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $101K | Hold |
|
|||||
|
2023
Q3 | $93.3K | Hold |
|
|||||
|
2023
Q2 | $100K | Hold |
|
|||||
|
2023
Q1 | $106K | Hold |
|
|||||
|
2022
Q4 | $125K | Hold |
|
|||||
|
2022
Q3 | $105K | Hold |
|
|||||
|
2022
Q2 | $77K | Hold |
|
|||||
|
2022
Q1 | $86K | Sell |
|
|||||
|
2021
Q4 | $179K | Hold |
|
|||||
|
2021
Q3 | $199K | Hold |
|
|||||
|
2021
Q2 | $179K | Hold |
|
|||||
|
2021
Q1 | $149K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $19K | Buy |
|